EP4065119
INITIAL TRIPLE COMBINATION THERAPY WITH MACITENTAN, TADALAFIL, AND SELEXIPAG FOR TREATING PULMONARY ARTERIAL HYPERTENSION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.11.2020EP published:
4.9.2024EP application number:
20820054.3
EPO information:
European Patent Register
Max expiry date:
26.11.2040
Title in English:
INITIAL TRIPLE COMBINATION THERAPY WITH MACITENTAN, TADALAFIL, AND SELEXIPAG FOR TREATING PULMONARY ARTERIAL HYPERTENSIONLanguage of the patent:
English
Timeline
Today
27.11.2020EP application
4.9.2024EP Publication
Owner
Name:
Actelion Pharmaceuticals LtdAddress:
Gewerbestrasse 16, 4123 Allschwil, CH
Inventor
Name:
MARESTA, AlessandroAddress:
4123 Allschwil, CH
Name:
PERCHENET, LoïcAddress:
4123 Allschwil, CH
Priority
Number:
201962941910 PDate:
29.11.2019Country:
US
Number:
202063023452 PDate:
12.5.2020Country:
US
Number:
202063076149 PDate:
9.9.2020Country:
US
Classification
Categories:
A61K 31/4965, A61K 31/4985, A61K 31/505, A61K 31/506, A61K 31/519, A61K 31/53, A61P 9/12, A61K 45/06